Description

5-[1-[[(1R,2R)-2-Aminocyclohexyl]Amino]Ethylidene]-1,3-Dimethyl-2,4,6(1H,3H,5H)-Pyrimidinetrione is a sophisticated chiral intermediate with significant utility in advanced organic synthesis. This compound matters for its role as a key building block in the development of pharmaceutically active molecules, particularly those targeting complex biological pathways. It is primarily needed by pharmaceutical R&D teams and fine chemical manufacturers engaged in producing high-value, optically pure active pharmaceutical ingredients (APIs) and novel chemical entities.

Application

• Pharmaceutical Intermediate: A critical chiral building block in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Asymmetric Synthesis: Utilized in the construction of complex molecular architectures requiring high enantiomeric purity due to its defined (1R,2R) stereochemistry.
• Protease Inhibitor Research: Serves as a core scaffold or precursor in the development of protease inhibitors, leveraging its pyrimidinetrione structure.
• Chemical Biology & Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies and library synthesis for hit-to-lead optimization.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for the production of client-specific target molecules under cGMP conditions.
• Academic Research: Used in university and institutional labs for methodological development in organic chemistry and catalysis.

Basic Information

Product Name	5-[1-[[(1R,2R)-2-Aminocyclohexyl]Amino]Ethylidene]-1,3-Dimethyl-2,4,6(1H,3H,5H)-Pyrimidinetrione
CAS No.	915222-02-5
Molecular Formula	C14H22N4O3
Molecular Weight	294.35 g/mol
Synonyms	1,3-Dimethyl-5-[(1-{[(1R,2R)-2-aminocyclohexyl]amino}ethylidene)barbituric acid; (1R,2R)-2-[(1-(1,3-Dimethyl-2,4,6-trioxohexahydropyrimidin-5-ylidene)ethyl)amino]cyclohexanamine; 5-(1-(((1R,2R)-2-Aminocyclohexyl)amino)ethylidene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione; Barbituric acid derivative, 5-[1-[[(1R,2R)-2-aminocyclohexyl]amino]ethylidene]-1,3-dimethyl-; Chiral barbiturate-cyclohexylamine conjugate.
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems, ensuring batch-to-batch consistency for critical R&D and scale-up work. Quality is verified through comprehensive analytical techniques including HPLC for purity and chiral integrity, NMR for structural confirmation, and mass spectrometry. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting key parameters such as assay, enantiomeric excess, and impurity profile. We support development under cGMP guidelines for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants or storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Enantiomeric Purity (Chiral HPLC)	≥ 99.0% e.e.
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.